SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-002070
Filing Date
2020-02-21
Accepted
2020-02-21 17:24:45
Documents
9
Period of Report
2020-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_022020.htm 8-K 44323
2 FORM OF WARRANT ex4-1.htm EX-4.1 109548
3 OPINION OF WEINTRAUB TOBIN CHEDIAK COLEMAN GRODIN ex5-1.htm EX-5.1 7015
4 FORM OF SECURITIES PURCHASE AGREEMENT ex10-1.htm EX-10.1 220472
5 PLACEMENT AGENCY AGREEMENT ex10-2.htm EX-10.2 85027
6 PRESS RELEASE ex99-1.htm EX-99.1 10210
7 PRESS RELEASE ex99-2.htm EX-99.2 13184
8 GRAPHIC ex10-2001.jpg GRAPHIC 4097
9 GRAPHIC ex99-1.jpg GRAPHIC 2866
  Complete submission text file 0001387131-20-002070.txt   500964
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 20641254
SIC: 2834 Pharmaceutical Preparations